A 2-dose regimen of the vaccine modified vaccinia Ankara-Bavarian Nordic (MVA-BN) can generate neutralizing antibodies for monkeypox virus clades Ib and IIb. We observed higher response to clade IIb; that result provides evidence that MVA-BN vaccination can induce cross-neutralizing antibodies for monkeypox virus clade Ib as well as for clade IIb.
Journal article
2026-02-01T00:00:00+00:00
32
302 - 305
3
MVA-BN vaccination, United Kingdom, monkeypox virus, mpox, neutralization, viruses, zoonoses, Humans, Antibodies, Viral, Monkeypox virus, Antibodies, Neutralizing, United Kingdom, Mpox, Monkeypox, Vaccination, Smallpox Vaccine, Adult, Female, Male, Vaccinia virus, Young Adult, Healthy Volunteers, Middle Aged